Cargando…
Prevention of hepatocellular carcinoma by targeting MYCN-positive liver cancer stem cells with acyclic retinoid
Hepatocellular carcinoma (HCC) is a highly lethal cancer that has a high rate of recurrence, in part because of cancer stem cell (CSC)-dependent field cancerization. Acyclic retinoid (ACR) is a synthetic vitamin A-like compound capable of preventing the recurrence of HCC. Here, we performed a genome...
Autores principales: | Qin, Xian-Yang, Suzuki, Harukazu, Honda, Masao, Okada, Hikari, Kaneko, Shuichi, Inoue, Ikuyo, Ebisui, Etsuko, Hashimoto, Kosuke, Carninci, Piero, Kanki, Keita, Tatsukawa, Hideki, Ishibashi, Naoto, Masaki, Takahiro, Matsuura, Tomokazu, Kagechika, Hiroyuki, Toriguchi, Kan, Hatano, Etsuro, Shirakami, Yohei, Shiota, Goshi, Shimizu, Masahito, Moriwaki, Hisataka, Kojima, Soichi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
National Academy of Sciences
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5949003/ https://www.ncbi.nlm.nih.gov/pubmed/29686061 http://dx.doi.org/10.1073/pnas.1802279115 |
Ejemplares similares
-
Acyclic retinoid in chemoprevention of hepatocellular carcinoma: Targeting phosphorylated retinoid X receptor-α for prevention of liver carcinogenesis
por: Shimizu, Masahito, et al.
Publicado: (2012) -
Dual induction of caspase 3- and transglutaminase-dependent apoptosis by acyclic retinoid in hepatocellular carcinoma cells
por: Tatsukawa, Hideki, et al.
Publicado: (2011) -
The Effect of Acyclic Retinoid on the Metabolomic Profiles of Hepatocytes and Hepatocellular Carcinoma Cells
por: Qin, Xian-Yang, et al.
Publicado: (2013) -
Synergistic growth inhibition by acyclic retinoid and phosphatidylinositol 3-kinase inhibitor in human hepatoma cells
por: Baba, Atsushi, et al.
Publicado: (2013) -
Targeting transglutaminase 2 mediated exostosin glycosyltransferase 1 signaling in liver cancer stem cells with acyclic retinoid
por: Qin, Xian-Yang, et al.
Publicado: (2023)